
Less gas, same grass: Bovaer, where is it now?
Maik Kindermann, VP of Innovation Bovaer at DSM-Firmenich, said: 'We have nothing to hide.'
Mr Kindermann began his presentation by addressing the elephant in the room and the recent public pushback surrounding the product. He acknowledged the social media attack on technologies like Bovaer, and the mistrust in such technical developments.
"…We have put all our research traditionally in front of the public, so we now have 92 scientific publications out. The reason why I'm saying this is that it's all publicly available,' he announced.
The additive 3-nitrooxypropanol (3-NOP), otherwise known as Bovaer, is a feed additive proven to reduce methane production in ruminants. It is said to reduce emissions by an average of 30% for dairy cattle, and up to 45% for beef cattle with their product.
The controversy
In February this year, Bovaer came under scrutiny from the general public, with misinformation taking root via social media.
The media storm began after Arla announced it would pilot a scheme with its farmers to feed Bovaer to their herds and reduce the carbon footprint of their production.
Just like that, an announcement that was expected to be celebrated as a multinational food group leaning into reducing its emissions and taking steps to be 'greener' was snowballed and associated with videos of people throwing away Arla products and pouring milk down kitchen sinks in protest.
What Arla and DSM-Firmenich were not expecting at the announcement was members of the public taking to social media, denouncing both Arla and the feed additive, with uproar focusing on the health effects of the product. Some social media users even made claims 3-NOP could cause cancer, which DSM-Firmenich denies.
Just like that, an announcement that was expected to be celebrated as a multinational food group leaning into reducing its emissions and taking steps to be 'greener' was snowballed and associated with videos of people throwing away Arla products and pouring milk down kitchen sinks in protest.
It is important to note Bovaer is metabolised in the cow, and 'we don't find it in milk and meat', explained Mr Kindermann. The additive does not pose a risk for people consuming the products from Bovaer-fed cows as a result.
Somehow, Bill Gates was also dragged into the spotlight through this media crucifixion, the Microsoft co-founder having no known connection to Bovaer or DSM-Firmenich, but has invested in Rumin8, a rival product using seaweed to reduce methane emissions rather than the synthetic compound 3-NOP.
The background of Bovaer
Mr Kindermann, a guest speaker at the British Society of Animal Science conference, discussed the creation and market expansion of Bovaer.
Research for the additive began at the end of 2008 for DSM-Firmenich, and Mr Kindermann, a chemist by trade, began looking into methane production in ruminants. When a ruminant digests its food, hydrogen is produced as a by-product. This, in turn, gets processed by microorganisms found in the rumen and is converted into methane in a seven-step process.
Mr Kindermann explained they decided to interfere in the last step of methane production for these microorganisms. This was because they had the crystal structure on file for that particular stage of the pathway, and this step did not occur anywhere else in the cow.
'So the idea was if we inhibit this enzyme very specifically, we exclude unwanted side-effects.'
In 2021, Brazil was the first country to commercially approve Bovaer, with Europe not far behind. Now, 68 countries have Bovaer as a commercially approved additive.
Once the pathway is infiltrated, the 3-NOP deactivates the targeted enzyme, which breaks down the molecule. Once broken apart, all products as a result of the feed additive are naturally occurring molecules found in the cow, which can all be metabolised.
'When you feed 3-NOP, the effect in reducing methane is immediate. So within 20-30 minutes, methane goes down,' said Mr Kindermann. If animals are not kept on the additive, then within three hours, methane production returns to normal.
Showing data from a three-month study, Mr Kindermann said: 'As long as you feed Bovaer, methane stays in this 20-30% reduction, and if you stop within a day or two, methane picks up again.
'Bovaer works from 100% grass-fed diets to complex TMR and also to finishing beef cattle diets… It always works, once it's in, it works,' Mr Kindermann explained proudly.
In 2021, Brazil was the first country to commercially approve Bovaer, with Europe not far behind. Now, 68 countries have Bovaer as a commercially approved additive. 'Bovaer has been tried around the world and is a trusted solution,' said Mr Kindermann.
Mr Kindermann explained there were several multi-year trials currently ongoing with ruminants on Bovaer. One year-long trial he showed at his presentation was conducted by Wageningen University & Research in the Netherlands, which found an increase in fat and protein by 6.4% in the animals fed the additive.
'You see a bit of an increase in milk fat and milk protein, which is a good effect on the cow. We have not seen any effect on health, fertility, and welfare behaviour,' said Mr Kindermann, who emphasised in its 16 years of trials and studies of its additive, it has so far not detected any adverse effects on animals ingesting Bovaer.
The future of Bovaer
Mr Kindermann revealed in his presentation that DSM-Firmenich was looking to expand Bovaer. As well as getting commercial approval in other countries such as China and India, too major global players that, if secured and Bovaer implemented, could make major changes in global methane emissions.
DSM-Firmenich is also working on formulating a slow-release Bovaer product to simplify the administration of the additive for farmers. Currently, the company is looking into a once-a-day additive with long-lasting effects to work on reducing methane within ruminants until the next feed. 'Our biggest problem is that these prototypes are too expensive for companies.'
Mr Kindermann also announced it was looking into a Bovaer additive for drinking water. '3NOP is perfectly water soluble,' he explained, saying a farmer would need 370g of Bovaer per litre of water. In initial testing of a water-soluble variant, Mr Kindermann said its trial saw a methane reduction of 20% in beef cattle and a reduction of 40% in methane in a sheep trial.
The company has also nearly completed the build for a dedicated plant in Dalry, Scotland, and is expected to be fully operational later this year.
Read More
Has climate change boosted the possibility of producing wine in Ireland?
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Agriland
8 hours ago
- Agriland
UFU: Farmers considering bluetongue vaccine should consult vet
The Ulster Farmers' Union (UFU) has advised farmers in Northern Ireland considering using a bluetongue vaccine to consult with their vet. The Department of Agriculture, Environment and Rural Affairs (DAERA) has permitted the voluntary use of three bluetongue serotype 3 (BTV-3) vaccines in Northern Ireland, subject to licensing. The UFU noted that Northern Ireland remains free of the virus and this decision provides livestock keepers with an additional tool as a precautionary, secondary line of defence against the disease. Bluetongue is a notifiable exotic viral disease which can cause severe clinical signs in ruminant species, such as cattle, sheep and goats, along with camelids. The virus, which does not pose a risk to human health or food safety, is primarily spread by the bite of infected midges, which are more active in warmer months Bluetongue UFU deputy president Glenn Cuddy said the approval of these vaccines may offer farmers 'another option in managing potential risks'. 'It's important to understand that while these vaccines do not prevent infection or transmission, they are intended to reduce the severity of clinical signs and mortality in affected animals. 'Any farmers who are considering vaccination must consult their private veterinary surgeon. 'This will enable them to discuss whether vaccination is appropriate for their specific livestock and farm system, taking into account factors such as the timings of any vaccination programme and future animal movements or buying and selling policies,' he said. 'Our primary aim remains to keep bluetongue out of Northern Ireland through robust bio-security measures, continued vigilance, and the safe sourcing of livestock. 'We urge all livestock keepers to remain vigilant for signs of BTV, especially as we enter the high-risk period, and to contact their private veterinary practitioner with any concerns,' Cuddy added. The UFU deputy president said that the decision to vaccinate is an individual one for each farmer, to be made in consultation with their veterinary professional. DAERA DAERA has said that if a farmer decides to vaccinate they must have a specific licence from the department to be able to obtain the vaccine. The department said that vaccinating animals does not impact on trade or movement of animals so long as Northern Ireland remains BTV-3 free. However, DAERA said that the use of vaccines may limit use of negative serology for germinal product certification to some third countries, requiring PCR instead. Farmers are being reminded that the direct movement of all live ruminants and camelids from Britain to Northern Ireland is still suspended and the use of approved unauthorised vaccines does not change this.


Agriland
11 hours ago
- Agriland
DAFM favours early detection of bluetongue over vaccine
The Department of Agriculture, Food and the Marine (DAFM) has said its current approach to bluetongue is early detection and eradication, where possible. Bluetongue is a notifiable exotic viral disease caused by bluetongue virus (BTV) which can cause severe clinical signs in ruminant species, such as cattle, sheep and goats, along with camelids. The virus, which does not pose a risk to human health or food safety, is primarily spread by the bite of infected midges, which are more active in warmer months Ireland is currently free from the disease, however remains at risk of introduction, as it the virus is present across Europe. Vaccine There are three inactivated vaccines currently available for bluetongue serotype-3 (BTV3) in Europe. DAFM said that all three vaccines claim to reduce the levels of virus in the blood of infected animals and reduce clinical signs of disease. However, they do not claim to prevent animals from becoming infected. 'This means that vaccinated animals may still be capable of becoming infected with the disease, increasing the risk of onward spread without displaying clinical signs of disease. 'This would likely delay early detection of disease, reducing the opportunity for the Department of Agriculture, Food and the Marine to use the appropriate controls necessary to prevent the virus from becoming widely established in the midge population. 'Once established in the midge population, bluetongue is very challenging to control,' a department spokesperson told Agriland. The spokesperson added that 'the department's current approach to bluetongue, as with all exotic diseases, is early detection and eradication, where possible'. 'In the event that bluetongue becomes established in the midge population and in susceptible animals in Ireland, vaccination would become an important tool to minimise production losses,' they said. DAFM said that it continues to monitor the bluetongue situation across Europe and Britain, with 'ongoing contingency planning' for the management of an outbreak of the disease in Ireland. The department said it also undertakes regular communication and collaboration with colleagues in Northern Ireland's Department of Agriculture, Environment and Rural Affairs (DAERA) in preparing for such an eventuality. Bluetongue On Wednesday (July 23), the DAERA permitted the voluntary use of three bluetongue serotype 3 (BTV-3) vaccines in Northern Ireland, subject to licensing. While Northern Ireland also remains free of the disease, DAERA said that livestock keepers and vets will now be able to take early, informed action as a precautionary, secondary line of defence against the disease. Minister for Agriculture, Environment and Rural Affairs, Andrew Muir said he took the decision to allow the use of the BTV-3 vaccines to give farmers and livestock keepers 'an additional safeguard alongside our surveillance, prompt detection and control'. 'It aims to provide an additional tool to help protect their flocks and herds,' the minister said. According to DAERA, the decision brings Northern Ireland into line with the voluntary, licensed use of BTV-3 vaccines in Scotland, Wales, and England, and reflects the evolving risk picture and demand for tools than can help build resilience against animal disease threats. Guidance is available on the DAERA website to farmers, veterinary surgeons and the wider industry on how the vaccine licensing process will work in practice. DAERA is urging all farmers to be vigilant for signs of the disease.


Agriland
2 days ago
- Agriland
DAERA approves voluntary BTV-3 vaccine in NI
The Department of Agriculture, Environment and Rural Affairs (DAERA) has permitted the voluntary use of three bluetongue serotype 3 (BTV-3) vaccines in Northern Ireland, subject to licensing. These vaccines are intended to reduce the severity of clinical signs and mortality in affected animals, though they do not prevent infection or transmission. While Northern Ireland remains free of the disease, livestock keepers and veterinary practitioners will now be able to take early, informed action as a precautionary, secondary line of defence against the disease. The Minister for Agriculture, Environment and Rural Affairs, Andrew Muir said: 'My department is continuing to take all necessary actions to protect Northern Ireland from an incursion of Bluetongue virus. This includes our recently published BTV-3 Disease Control Framework. 'While we remain BTV free, I have now taken the decision to allow the use of the BTV-3 vaccines to give our farmers and livestock keepers an additional safeguard alongside our surveillance, prompt detection and control. 'It aims to provide an additional tool to help protect their flocks and herds,' the minister added. DAERA According to DAREA, the decision brings Northern Ireland into line with the voluntary, licensed use of BTV-3 vaccines in Scotland, Wales, and England, and reflects the evolving risk picture and demand for tools than can help build resilience against animal disease threats. The Chief Veterinary Officer, Brian Dooher said: 'Clear guidance is available on the DAERA website to farmers, veterinary surgeons and the wider industry on how the vaccine licensing process will work in practice. 'We continue to urge all livestock keepers to remain vigilant for the signs of BTV as we enter the high-risk period and advise them to contact their private veterinary practitioner should they have any concerns,' Dooher added. DAERA is urging all farmers to be vigilant for sings of the disease.